Jeffrey Lawrence Schwartz's Net Worth

$514 Million

Who is Jeffrey Lawrence Schwartz?

Jeffrey Lawrence Schwartz has an estimated net worth of $514 Million. This is based on reported shares across multiple companies, which include Dicerna Pharmaceuticals Inc, MARINUS PHARMACEUTICALS INC, RAPID MICRO BIOSYSTEMS, INC., Arcutis Biotherapeutics, Inc., Replimune Group, Inc., Annexon, Inc., Aptinyx Inc., BCLS Acquisition Corp., and SpringWorks Therapeutics, Inc..

SEC CIK

Jeffrey Lawrence Schwartz's CIK is 0001702957

Past Insider Trading and Trends

2020 was Jeffrey Lawrence Schwartz's most active year for acquiring shares with 9 total transactions. Jeffrey Lawrence Schwartz's most active month to acquire stocks was the month of April. 2017 was Jeffrey Lawrence Schwartz's most active year for disposing of shares, totalling 6 transactions. Jeffrey Lawrence Schwartz's most active month to dispose stocks was the month of November. 2020 saw Jeffrey Lawrence Schwartz paying a total of $26,674,988.00 for 11,049,217 shares, this is the most they've acquired in one year. In 2021 Jeffrey Lawrence Schwartz cashed out on 44,122,820 shares for a total of $173,925,000.00, their largest year based on trade value.